Identification of a Novel Hb H Disease with Glucose-6-Phosphate Dehydrogenase Deficiency Using Whole Genome Sequencing

Hemoglobin. 2022 May;46(3):160-163. doi: 10.1080/03630269.2022.2070072. Epub 2022 May 17.

Abstract

With the development of sequencing technology, more and more rare thalassemia types have been found. In this article, we found a novel Hb H disease combined with glucose-6-phosphate dehydrogenase (G6PD) deficiency through whole genome sequencing (WGS), which was verified by Sanger sequencing and polymerase chain reaction (PCR)-reverse dot-blot hybridization, respectively.

Keywords: Hb H disease; Novel α deletion; thalassemia; whole genome sequencing (WGS).

MeSH terms

  • Glucosephosphate Dehydrogenase / genetics
  • Glucosephosphate Dehydrogenase Deficiency* / diagnosis
  • Glucosephosphate Dehydrogenase Deficiency* / genetics
  • Humans
  • Polymerase Chain Reaction
  • Thalassemia* / genetics
  • Whole Genome Sequencing

Substances

  • Glucosephosphate Dehydrogenase